Trytosaveabit commented on a stock · Nov 7, 2023 09:11

Update

$Monte Rosa Therapeutics(GLUE.US)$ Monte Rosa Therapeutics Presents Preclinical Data At ACR Convergence 2023 Demonstrating Potential Of MRT-6160, A VAV1-Targeted Molecular Glue Degrader, To Treat Immunological And Inflammatory Diseases

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

2451 Views

Comment

Trytosaveabit

1733Followers

28Following

20KVisitors